Myocardial infarction during nilotinib treatment in a low-risk patient for cardiovascular events: underrecognized cardiotoxicity of tyrosine kinase inhibitors?

15 October 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Clinical Cases ST-elevation myocardial infarction - ACS ACVC Premium Access Acute Cardiovascular Care 2016

ESC 365 is supported by

ESC 365 is supported by